ATE547709T1 - Tumorinvasionsfördernde peptidsequenz - Google Patents

Tumorinvasionsfördernde peptidsequenz

Info

Publication number
ATE547709T1
ATE547709T1 AT06837610T AT06837610T ATE547709T1 AT E547709 T1 ATE547709 T1 AT E547709T1 AT 06837610 T AT06837610 T AT 06837610T AT 06837610 T AT06837610 T AT 06837610T AT E547709 T1 ATE547709 T1 AT E547709T1
Authority
AT
Austria
Prior art keywords
opn
growth
patient
expression
peptide sequence
Prior art date
Application number
AT06837610T
Other languages
English (en)
Inventor
F Weber Georg
Original Assignee
Metamol Theranostics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metamol Theranostics Llc filed Critical Metamol Theranostics Llc
Application granted granted Critical
Publication of ATE547709T1 publication Critical patent/ATE547709T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06837610T 2005-11-14 2006-11-14 Tumorinvasionsfördernde peptidsequenz ATE547709T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73619305P 2005-11-14 2005-11-14
PCT/US2006/044257 WO2007059166A2 (en) 2005-11-14 2006-11-14 Peptide sequence that promotes tumor invasion

Publications (1)

Publication Number Publication Date
ATE547709T1 true ATE547709T1 (de) 2012-03-15

Family

ID=38049253

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06837610T ATE547709T1 (de) 2005-11-14 2006-11-14 Tumorinvasionsfördernde peptidsequenz

Country Status (4)

Country Link
US (2) US7807790B2 (de)
EP (2) EP1949109B1 (de)
AT (1) ATE547709T1 (de)
WO (1) WO2007059166A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101293924A (zh) * 2007-04-24 2008-10-29 上海国健生物技术研究院 骨桥蛋白的功能表位、与其特异性结合的单克隆抗体及其在制备抗肿瘤转移药物中的用途
US9587278B2 (en) * 2010-01-08 2017-03-07 Oxford Gene Technology (Operations) Ltd. Combined CGH and allele specific hybridisation method
EP3679061A4 (de) * 2017-09-06 2021-06-09 University of Cincinnati Verfahren zur prognose von brustläsionen im frühstadium
CN109705221B (zh) * 2018-12-27 2021-03-09 美康生物科技股份有限公司 C肽免疫原及其单克隆抗体对及该抗体对在c肽磁微粒化学发光免疫试剂中的应用
US20230203193A1 (en) * 2020-06-03 2023-06-29 Georg F. Weber Isolated antibodies and fragments thereof with specificity for osteopontin-c
EP4244392A1 (de) * 2020-11-16 2023-09-20 Inserm (Institut National De La Sante Et De La Recherche Medicale) Verfahren und zusammensetzungen zur vorhersage und behandlung von uvealem melanom

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
DE3689123T2 (de) 1985-11-01 1994-03-03 Xoma Corp Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
CA1319101C (en) 1986-09-03 1993-06-15 Marta Iris Sabara Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DE68927933T2 (de) 1988-09-02 1997-08-14 Dyax Corp Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
ES2139598T3 (es) 1990-07-10 2000-02-16 Medical Res Council Procedimientos para la produccion de miembros de parejas de union especifica.
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
DE69233697T2 (de) 1991-03-01 2008-01-24 Dyax Corp., Cambridge Verfahren zur Entwicklung von bindenden Mikroproteinen
PT100379B (pt) 1991-04-10 1999-01-29 Scripps Research Inst Bibliotecas de receptores heterodimericos usando fagomideos
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
WO2002071928A2 (en) * 2001-03-14 2002-09-19 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
US7125663B2 (en) * 2001-06-13 2006-10-24 Millenium Pharmaceuticals, Inc. Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
AU2002322280A1 (en) 2001-06-21 2003-01-21 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US20040142865A1 (en) * 2002-10-02 2004-07-22 Weber Georg F. Osteopontin-based cancer therapies
IT1395574B1 (it) 2009-09-14 2012-10-16 Guala Dispensing Spa Dispositivo di erogazione

Also Published As

Publication number Publication date
US7807790B2 (en) 2010-10-05
EP2365334A1 (de) 2011-09-14
US8969020B2 (en) 2015-03-03
EP1949109B1 (de) 2012-02-29
WO2007059166A2 (en) 2007-05-24
EP1949109A4 (de) 2008-12-03
US20090061436A1 (en) 2009-03-05
EP1949109A2 (de) 2008-07-30
US20110033857A1 (en) 2011-02-10
WO2007059166A3 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
Sala et al. A complex and evolutive character: two face aspects of ECM in tumor progression
SI1404811T1 (sl) Ogljikov monoksid izboljša rezultate pri presaditvi tkiva in organov ter prepreči apoptozo
ATE252601T1 (de) Lang wirkende insulinotrope peptide
PL1771474T3 (pl) Inhibitory białka angiopoetyno-4-podobnego, kombinacje i ich zastosowanie
CY1105212T1 (el) Αντισωματα αντι-april και κυτταρα υβριδωματος
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
WO2008083326A3 (en) Targeting of ews-fli1 as anti-tumor therapy
NO20064794L (no) Anvendelse av anti-alfa5beta1-antistoffer for inhibering av kreftcelleproliferasjon
ATE424461T1 (de) Modifizierte zytokine für krebs therapie
EP1949109A4 (de) Tumorinvasionsfördernde peptidsequenz
DE60033918D1 (de) Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
DE60032784D1 (de) Markerproteine für prostatakrebs
CY1113424T1 (el) Μεθοδος αντιμετωπισης του καρκινου ή/και παθησεις με κυτταρικη υπερπλασια και παραγοντες που στοχευουν τον αναβολισμο υαλουρονανης για τον ιδιο σκοπο
TR200103457T2 (tr) 4-Fenil-Pirimidin Türevleri.
PT1147087E (pt) Feantridina-n-oxidos com actividade de inibicao de pde-iv
DE60229867D1 (de) Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
TW200501998A (en) Labeling peptide for nasopharyngeal carcinoma (NPC) cells
DE60327710D1 (de) Modifizierte zytokine für krebs therapie
CY1106289T1 (el) Χρηση αναστολεων υποδοχεος προγεστepονης για τη θepαπευτικη αντιμετωπιση του καρκινου του μαστου που ειναι ανθεκτικος σε στepοειδη
ATE293991T1 (de) VERWENDUNG EINES MIT DEM PEPTID ßELAGIGILTVß ASSOZIIERTEN ENTEROBAKTERIEN-PROTEINS OMPA ZUR BEHANDLUNG VON MELANOMEN
ATE362535T1 (de) Mutiertes cyclin g1 protein
BRPI0707247B8 (pt) vacina para tumor compreendendo células tumorais alogênicas ou xenogênicas
WO2001055450A3 (en) AMPLIFIED GENES AT 17q23
CN208479700U (zh) 一种能杀菌的浴室手机支架
NO20040174L (no) Fremgangsmate for donorspesifikk krysstilpasning